Tirzepatide significantly reduces cardiovascular risk in high-risk patients
Summary
Two new studies show that tirzepatide, a glucose-dependent insulinotropic polypeptide (GIP) receptor and glucagon-like peptide-1 (GLP-1) receptor agonist (RA), ...
Description
Two new studies show that tirzepatide, a glucose-dependent insulinotropic polypeptide (GIP) receptor and glucagon-like peptide-1 (GLP-1) receptor agonist (RA), ...
Original reporting
AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.
Open original source